找化学品上960化工网!
960化工网

左布地奈德 | 51333-22-3

左布地奈德
Budesonide
51333-22-3
C25H34O6
430.5339
如需查看该化合物的详细结构式,mol文件,smile,InChi 请点击:左布地奈德结构式
5281004
左布地奈德价格
简介
Budesonide 是一种吸入型糖皮质类固醇,具有口服活性的糖皮质激素受体 (glucocorticoid receptor) 激动剂。Budesonide 可减少肺部肿瘤的大小,逆转 DNA 低度甲基化并调节基因的 mRNA 表达。Budesonide 是一种可以用于哮喘的抗炎药。
名称和标识符
MDL MFCD00083259
InChIKey VOVIALXJUBGFJZ-VXKMTNQYSA-N
Inchi 1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21+,22+,23-,24-,25+/m0/s1
SMILES O1[C@]([H])(C([H])([H])C([H])([H])C([H])([H])[H])O[C@]2([H])C([H])([H])[C@@]3([H])[C@]4([H])C([H])([H])C([H])([H])C5=C([H])C(C([H])=C([H])[C@]5(C([H])([H])[H])[C@@]4([H])[C@]([H])(C([H])([H])[C@]3(C([H])([H])[H])[C@]12C(C([H])([H])O[H])=O)O[H])=O
别名信息
- 中文别名 -
  • 左布地奈德
  • 布地奈德
  • S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮
  • 布地奈德 EP5
  • 布地奈德 USP标准品
  • 布地奈德(非对映体混合物)
  • 布地奈德,USP,EP,BP
  • 布地奈德-D8
  • 布地奈德-D8 标准品
  • 布地奈德标准品
  • 布地奈德混悬剂
  • 布地奈德杂质K
  • 地索奈德
  • 16alpha,17alpha-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11beta,21-二羟基-3,20二酮
  • 16α,17α-22R,S-丙基亚甲基二氧-孕甾-1,4-二烯-11β,21-二羟基-3,20 二酮
  • 布德松
  • 布地拉德
  • 布地缩松 标准品
  • 右布地奈德
  • 布地缩松
- 英文别名 -
  • S-budesonide
  • Budesonide
  • Budesonide (Rhinocort®, Pulmicort® , Entocort®, Symbicort®, Noex®, Entocort EC®)
  • Budesonide,(11β,16α)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
  • 16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
  • BIDIEN
  • Budeson
  • Entocort
  • Micronyl
  • PREFERID
  • PULMICORT
  • Respules
  • RHINOCORT
  • S-1320
  • SPIROCORT
  • 16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
  • Dexbudesonide
  • (22R)-Budesonide
  • 2HI1006KPH
  • DSSTox_CID_202
  • DSSTox_RID_75430
  • DSSTox_GSID_20202
  • Dexbudesonide [INN]
  • R-Budesonide
  • BUDESONIDE (11beta,16alpha(R))
  • (4aR,4bS,5S,6aS,6b
  • BPBio1_000523
  • Prestwick2_000518
  • UCERIS COMPONENT BUDESONIDE
  • HMS3260D09
  • budesonide
  • Cortivent
  • Budesonide Easyhaler
  • MLS002207112
  • Budesonide, >=99%
  • BSPBio_000475
  • D07AC09
  • 16A(R),17-(BUTYLIDENEBIS(OXY))-11B,21-DIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE
  • EU-0100174
  • NC00626
  • (11?,16?)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
  • BUDESONIDE [EP MONOGRAPH]
  • Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
  • CS-0695032
  • BUDESONIDE [USP-RS]
  • Bidien
  • R01AD05
  • BUDESONIDE [JAN]
  • Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-
  • EINECS 257-139-7
  • BDBM50354850
  • NS00000099
  • Rhinocort Allergy
  • BUDESONIDE (EP MONOGRAPH)
  • BUDESONIDE [USP MONOGRAPH]
  • Jorveza
  • SPBio_002396
  • BUDESONIDE [ORANGE BOOK]
  • 51333-22-3 , Budesonide, 11beta, 16alpha
  • Miflonide
  • CCRIS 5230
  • BB164267
  • Epitope ID:161750
  • Q422212
  • BUDESONIDE COMPONENT OF AIRSUPRA
  • Budecort Inhaler
  • Budesonidum
  • Budesonido
  • MLS000028507
  • Prestwick0_000518
  • A07EA06
  • BUDESONIDE [WHO-DD]
  • J-504150
  • Rhinocort
  • Budesonide (anti-inflammatory)
  • (+)-16alpha,17alpha-Butylidenedioxy-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
  • Spirocort
  • NCGC00259376-01
  • Eltair
  • Prestwick3_000518
  • Entocort EC
  • NSC-757788
  • Budesonide Inhalation Suspension
  • R03BA02
  • SR-01000000101-2
  • MAP-0010
  • Pulmicort turbuhaler
  • ORTIKOS
  • Inflammide
  • CAS-51333-22-3
  • UNII-Q3OKS62Q6X
  • BUDESONIDE (USP-RS)
  • T70986
  • Budesonide (Standard)
  • ENTOCORTEC
  • Uceris
  • Tox21_201827
  • NCGC00256415-01
  • BUDESONIDE (USP MONOGRAPH)
  • MFCD00083259
  • Pulmicort Flexhaler
  • MAP0010
  • 16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
  • DTXCID50820058
  • DB01222
  • SYMBICORT COMPONENT BUDESONIDE
  • Pulmicort Topinasal
  • BUDESONIDE [INN]
  • CS-2063
  • (R)-Budesonide
  • CHEMBL1370
  • Q-101375
  • HSDB 8279
  • Entocort EC (TN)
  • Budesonide Inhalation
  • BCP05589
  • Tox21_302815
  • BREZTRI COMPONENT BUDESONIDE
  • Pulmicort Respules
  • Ultesa
  • Budesonido (INN-Spanish)
  • Budesonide MMX
  • Budenofalk
  • Rhinocort (TN)
  • Nasocort
  • Pulmaxan turbohaler
  • NCGC00021318-08
  • HMS2232D17
  • Budecort
  • Tarpeyo
  • Pulmicort (TN)
  • SR-01000000101-6
  • HMS3259H07
  • AKOS015969655
  • SCHEMBL4096
  • S 1320
  • Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta,16-alpha)-
  • Budesonida
  • Q3OKS62Q6X
  • NCGC00089747-04
  • Lopac0_000174
  • Budesonide (JAN/USP/INN)
  • LP00174
  • Prestwick_840
  • Preferid
  • (11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
  • Budesonide [USAN:INN:BAN:JAN]
  • Giona Easyhaler
  • Fvolir
  • Tox21_110653
  • BUDESONIDE [MI]
  • BUDESONIDE [VANDF]
  • Budesonide, European Pharmacopoeia (EP) Reference Standard
  • AC-4697
  • (6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one
  • HMS3713H17
  • Tox21_500174
  • HY-13580
  • Budesonide, United States Pharmacopeia (USP) Reference Standard
  • HMS2096H17
  • Prestwick1_000518
  • CPD000058337
  • Budesonido [INN-Spanish]
  • Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11.beta.,16.alpha.)-
  • 11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
  • 51372-29-3
  • Budesonide
  • 16?,17-[(1RS)-butylidenebis(oxy)]-11?,21-dihydroxypregna-1,4-diene-3,20-dione
  • NCGC00021318-18
  • HMS1569H17
  • CHEBI:3207
  • Budesonidum (INN-Latin)
  • NCGC00016862-01
  • HMS3413B08
  • Pulmicort
  • (4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
  • HMS3677P17
  • CCG-204269
  • GTPL7434
  • Budiair
  • NCGC00260859-01
  • Budesonidum (Latin)
  • SDCCGSBI-0050162.P002
  • (1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one
  • BUDESONIDE COMPONENT OF UCERIS
  • HY-13580R
  • BUDESONIDE [USAN]
  • (11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
  • PULMICORTFLEXHALER
  • SMR000058337
  • AIRSUPRA COMPONENT BUDESONIDE
  • Uceris (TN)
  • Eohilia (budesonide oral suspension)
  • Budesonide 100 microg/mL in Acetonitrile
  • 5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
  • SR-01000000101
  • Butacort
  • Rhinocort alpha
  • MLS001077323
  • B3909
  • Opera_ID_1696
  • Budesonidum [INN-Latin]
  • BRD-A34299591-001-03-4
  • Noex
  • HMS3413P17
  • KS-1162
  • 51333-22-3
  • B 7777
  • NSC 757788
  • Rhinocort Aqua
  • (RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
  • BUDESONIDE COMPONENT OF BREZTRI
  • BudesonideInhalation Suspension
  • NCGC00021318-06
  • BUDESONIDE (ENTERIC COATED)
  • Pulmaxan
  • HMS3677B08
  • (6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one
  • BUDESONIDE COMPONENT OF SYMBICORT
  • Budesonide, Pharmaceutical Secondary Standard
  • Certified Reference Material
  • NCGC00021318-05
  • EN300-19737584
  • D00246
  • DTXSID8020202
物化性质
实验特性
LogP 2.71680
PSA 93.06000
Merck 14,1468
折射率 1.4593 (estimate)
沸点 599.7°C at 760 mmHg
熔点 235-245°C
闪点 201.8±23.6 °C
溶解度 生物体外In Vitro:DMSO溶解度215 mg/mL(499.38 mM;Need ultrasonic and warming)
颜色与性状 No data available
比旋光度 +100° - +110° (c=0.28, CH2Cl2)
密度 1.1046 (rough estimate)
计算特性
精确分子量 430.23600
氢键供体数量 2
氢键受体数量 6
可旋转化学键数量 4
同位素质量 430.236
重原子数量 31
复杂度 862
同位素原子数量 0
确定原子立构中心数量 8
不确定原子立构中心数量 1
确定化学键立构中心数量 0
不确定化学键立构中心数量 0
共价键单元数量 1
疏水参数计算参考值(XlogP) 2.5
拓扑分子极性表面积 93.1
国际标准相关数据
EINECS 257-161-7
海关数据
海关编码 29372900
海关数据

中国海关编码:

29372900
生产方法和用途
用途
治疗皮肤病、哮喘等。
专业数据库参考
PubChemId 5281004
化合物详情(旧版)

左布地奈德物理化学性质

熔点:221-232°C (dec.)

左布地奈德产品用途

用于治疗皮肤病、哮喘等病症


左布地奈德储运特性

库房通风低温干燥

产品用途
用于治疗皮肤病、哮喘等病症
左布地奈德推荐生产厂家
960化工网为您提供左布地奈德专业化合物百科信息,包括中文名,英文名,分子式,分子量,以及该化合物的CasNo.:51333-22-3,和相关理化性质;并提供了优质生产厂家信息包括厂家名称和联系方式等;| WAP 版:51333-22-3
平台客服 平台客服

平台在线客服